KLF4 is a Therapeutically Tractable Brake on Fibroblast Activation That Promotes Resolution of Pulmonary Fibrosis

Overview

Journal JCI Insight

Specialties Biomedical Engineering
General Medicine

Date 2022 Jul 19

PMID 35852857

Authors

Loka R Penke

Jennifer M Speth

Steven K Huang

Sean M Fortier

Jared Baas

Marc Peters-Golden

Affiliations

Soon will be listed here.

Abstract

There is a paucity of information about potential molecular brakes on the activation of fibroblasts that drive tissue fibrosis. The transcription factor Krüppel-like factor 4 (KLF4) is best known as a determinant of cell stemness and a tumor suppressor. We found that its expression was diminished in fibroblasts from fibrotic lung. Gain- and loss-of-function studies showed that KLF4 inhibited fibroblast proliferation, collagen synthesis, and differentiation to myofibroblasts, while restoring their sensitivity to apoptosis. Conditional deletion of KLF4 from fibroblasts potentiated the peak degree of pulmonary fibrosis and abrogated the subsequent spontaneous resolution in a model of transient fibrosis. A small molecule inducer of KLF4 was able to restore its expression in fibrotic fibroblasts and elicit resolution in an experimental model characterized by more clinically relevant persistent pulmonary fibrosis. These data identify KLF4 as a pivotal brake on fibroblast activation whose induction represents a therapeutic approach in fibrosis of the lung and perhaps other organs.

Citing Articles

Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38α inhibition.

Baas J, Varga J, Feghali-Bostwick C, Peters-Golden M, Fortier S bioRxiv. 2025; .

PMID: 40060695 PMC: 11888450. DOI: 10.1101/2025.02.26.640163.

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.

PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.

Comprehensive transcription factor perturbations recapitulate fibroblast transcriptional states.

Southard K, Ardy R, Tang A, OSullivan D, Metzner E, Guruvayurappan K bioRxiv. 2024; .

PMID: 39131349 PMC: 11312553. DOI: 10.1101/2024.07.31.606073.

MBNL2 promotes aging-related cardiac fibrosis via inhibited SUMOylation of Krüppel-like factor4.

Lu J, Zhao Q, Wang L, Li J, Wang H, Lv L iScience. 2024; 27(7):110163.

PMID: 38974966 PMC: 11226984. DOI: 10.1016/j.isci.2024.110163.

Highlighting fibroblast plasticity in lung fibrosis: the WI-38 cell line as a model for investigating the myofibroblast and lipofibroblast switch.

Vasquez-Pacheco E, Marega M, Lingampally A, Fassy J, Truchi M, Goth K Theranostics. 2024; 14(9):3603-3622.

PMID: 38948058 PMC: 11209726. DOI: 10.7150/thno.93519.

References

Local A, Zhang H, Benbatoul K, Folger P, Sheng X, Tsai C . APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells. Mol Cancer Ther. 2018; 17(6):1177-1186. DOI: 10.1158/1535-7163.MCT-17-1209. View

Zhang Y, Wang Y, Liu Y, Wang N, Qi Y, Du J . Krüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation. PLoS One. 2013; 8(4):e63424. PMC: 3640021. DOI: 10.1371/journal.pone.0063424. View

Zhang P, Andrianakos R, Yang Y, Liu C, Lu W . Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J Biol Chem. 2010; 285(12):9180-9. PMC: 2838337. DOI: 10.1074/jbc.M109.077958. View

Murray L, Chen Q, Kramer M, Hesson D, Argentieri R, Peng X . TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol. 2010; 43(1):154-62. DOI: 10.1016/j.biocel.2010.10.013. View

Hu B, Wu Z, Nakashima T, Phan S . Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis. Am J Pathol. 2012; 180(6):2257-67. PMC: 3378850. DOI: 10.1016/j.ajpath.2012.02.010. View

Penke L, Huang S, White E, Peters-Golden M . Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A. J Biol Chem. 2014; 289(24):17151-62. PMC: 4059156. DOI: 10.1074/jbc.M114.558130. View

Lin L, Han Q, Xiong Y, Li T, Liu Z, Xu H . Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition. Sci Rep. 2017; 7(1):15847. PMC: 5696468. DOI: 10.1038/s41598-017-14602-7. View

Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H . Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011; 121(7):2736-49. PMC: 3223832. DOI: 10.1172/JCI45444. View

Li S, Zhou Q, He H, Zhao Y, Liu Z . Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4). J Biol Chem. 2013; 288(6):4076-84. PMC: 3567659. DOI: 10.1074/jbc.M111.317487. View

10.

Wettlaufer S, Penke L, Okunishi K, Peters-Golden M . Distinct PKA regulatory subunits mediate PGE inhibition of TGFβ-1-stimulated collagen I translation and myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol. 2017; 313(4):L722-L731. PMC: 6148086. DOI: 10.1152/ajplung.00131.2017. View

11.

Huang S, White E, Wettlaufer S, Grifka H, Hogaboam C, Thannickal V . Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J. 2009; 23(12):4317-26. PMC: 2812040. DOI: 10.1096/fj.08-128801. View

12.

Shen Y, Miao N, Wang B, Xu J, Gan X, Xu D . c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling. Kidney Int. 2017; 92(4):888-899. DOI: 10.1016/j.kint.2017.03.006. View

13.

Aran D, Looney A, Liu L, Wu E, Fong V, Hsu A . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019; 20(2):163-172. PMC: 6340744. DOI: 10.1038/s41590-018-0276-y. View

14.

Chapman H . Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol. 2010; 73:413-35. DOI: 10.1146/annurev-physiol-012110-142225. View

15.

Milam J, Keshamouni V, Phan S, Hu B, Gangireddy S, Hogaboam C . PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2007; 294(5):L891-901. PMC: 5926773. DOI: 10.1152/ajplung.00333.2007. View

16.

Pham T, Lee J, Guan J, Caporarello N, Meridew J, Jones D . Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis. JCI Insight. 2022; 7(6). PMC: 8986080. DOI: 10.1172/jci.insight.153672. View

17.

Suzuki K, Kim J, Ugai K, Matsuda S, Mikami H, Yoshioka K . Transcriptomic changes involved in the dedifferentiation of myofibroblasts derived from the lung of a patient with idiopathic pulmonary fibrosis. Mol Med Rep. 2020; 22(2):1518-1526. PMC: 7339813. DOI: 10.3892/mmr.2020.11218. View

18.

Wang B, Shen A, OuYang X, Zhao G, Du Z, Huo W . KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells. Biochem Biophys Res Commun. 2017; 484(3):486-492. DOI: 10.1016/j.bbrc.2017.01.062. View

19.

Fortier S, Penke L, King D, Pham T, Ligresti G, Peters-Golden M . Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions. JCI Insight. 2021; 6(6). PMC: 8026183. DOI: 10.1172/jci.insight.144799. View

20.

Kong X, Li L, Li Z, Le X, Huang C, Jia Z . Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer. Cancer Res. 2013; 73(13):3987-96. PMC: 3702645. DOI: 10.1158/0008-5472.CAN-12-3859. View